The European Partnership for Personalized Medicine (PerMed)—a partnership dedicated to implementing personalized medicine approaches for the benefit of patients and society as a whole—will launch a joint transnational call for proposals titled “Cell and Gene Therapy for Personalized Medicine (CGT4PM2027)” in early November 2026. The goal…
Fostering a European Research Area for Health (ERA4Health): a partnership aimed at establishing flexible and effective coordination among research funding organizations in the European Research Area (ERA) in priority areas addressing European public health needs, will announce at the end of October 2026…
The European Partnership for Personalized Medicine (EP PerMed) platform offers an easily accessible space for establishing new collaborations. Its goal is to connect researchers, clinicians, companies, patients, representatives of regulatory authorities, and other key stakeholders in the field of personalized medicine. This collaboration will create an international…
On July 1, 2026, the European Partnership for Rare Diseases (ERDERA) announced a new call for proposals, the Clinical Trial Call 2026 (ECTC). The call supports transnational early-phase interventional clinical trials in the field of rare diseases that are conducted in accordance with the principles of Good Clinical Practice (Good Clinical…
On June 3, 2026, the European Rare Diseases Research Alliance (ERDERA) published a notice regarding the new Clinical Trial Call 2026 (ECTC), which will be launched on July 1, 2026. This call will support transnational Phase I and Phase I/II interventional clinical trials…
The International Consortium for Personalized Medicine (ICPerMed) invites you to a webinar focused on sharing experiences and examples of best practices in the field of personalized (precision) medicine. The webinar will take place on May 28, 2026, from 3:00 p.m. to 4:30 p.m. CEST. The keynote speaker will be Dr. Étienne Richer, Director…
The Ministry of Health / the ČR Health Research Agency ČR joined the so-called Widening Process following the first round of the transnational THCS (Transforming Health and Care System) partnership call: “Access to Care 2026.” What is the Widening Process? In the second round of the EP THCS call, Czech researchers…
The Ministry of Health / ČR Health Research Agency ČR the so-called Widening Process following the first round of the transnational call for proposals under the European Partnership for Personalised Medicine (EP PerMed): Personalised Medicine for CARdiovascular, MEtabolic, and Kidney Diseases (“CARMEN 2026”). What is the Widening Process? In the second round of the call…
Artificial intelligence (AI) is transforming medicine and research—and the next ERA4Health partnership webinar will focus on its practical applications. The event will take place online on Tuesday, May 12, 2026, at 10:00 a.m. CET. The keynote speaker will be Stéphanie Allassonnière from the University of Paris…
The document “Common Errors in the National Mandatory Annex to the Application Form,” which was first published last year, has now been updated. The new version provides more detailed instructions on how to complete the form correctly, including basic information, the involvement of Czech partners, and the financial aspects of the project. We therefore recommend that all applicants…